Latest Investor Presentations News

Judo Capital Holdings clarifies its recent Q3 financial disclosures, affirming compliance with ASX rules while highlighting FY26 profit guidance as material information.

Maas Group Holdings has reaffirmed its FY25 underlying EBITDA guidance of $215 million to $245 million, driven by recent acquisitions and growth in construction materials and renewable energy sectors.

National Australia Bank has reported robust half-year results with cash earnings of $3.58 billion and announced a fully franked interim dividend of 85 cents per share, underscoring its strong market position and strategic clarity.

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Australian Strategic Materials (ASM) outlines progress on its Korean Metals Plant ramp-up, strategic plans for a US metals facility, and conditional funding support for the Dubbo Project, reinforcing its mine-to-metals supply chain ambitions.

African Gold has forged a strategic alliance with Montage Gold, raising over A$9 million and advancing exploration at its Didievi Gold Project with promising high-grade drilling results.

McLaren Minerals has advanced its McLaren Titanium Project with a $1.5 million capital raise, ongoing drilling revealing promising heavy mineralisation, and key leadership changes signaling a strategic push toward development.

Brightstar Resources Limited reveals an ambitious growth strategy targeting a significant production ramp-up in 2025, anchored by its Laverton and Menzies hubs and supported by a robust mineral resource base.

Intelligent Monitoring Group Limited (IMG) has agreed to acquire KOBE Pty Ltd for an initial $6.98 million, aiming to expand its commercial security footprint in Queensland and boost FY25 EBITDA by approximately $2.5 million.

Krakatoa Resources has provided a detailed update on its Zopkhito Antimony-Gold Project in Georgia, revealing significant exploration data and a strategic plan to advance towards JORC-compliant resources.

SomnoMed Limited prepares to unveil its H1FY25 financial results on February 28, 2025, accompanied by a live investor presentation and Q&A session. The company remains a global leader in sleep apnea treatment solutions.

Microba Life Sciences reports a remarkable 102% revenue increase in Q2 FY25, driven by strong sales of its MetaXplore test in Australia and promising early traction in the UK. The company also advances its therapeutic pipeline with key clinical milestones.